Amyloid‐beta misfolding and GFAP predict risk of clinical Alzheimer's disease diagnosis within 17 years

Association of plasma biomarkers, p‐tau181, glial fibrillary acidic protein, and neurofilament light, with intermediate and long‐term clinical Alzheimer's disease risk: Results from a prospective cohort followed over 17 years

(2022) Hannah Stocker et al.   Alzheimers & Dementia

Current advances in plasma and cerebrospinal fluid biomarkers in Alzheimer's disease

(2021) Antoine Leuzy et al.   CURRENT OPINION IN NEUROLOGY

Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease

(2021) Alexis Moscoso et al.   JAMA Neurology

Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease

(2021) Pratishtha Chatterjee et al.   Translational Psychiatry

Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau

(2021) Niklas Mattsson‐Carlgren et al.   EMBO Molecular Medicine

Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease

(2021) Pratishtha Chatterjee et al.   Alzheimers & Dementia

Glial fibrillary acidic protein: a blood biomarker to differentiate neurodegenerative from psychiatric diseases

(2021) Henrik Zetterberg   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Prediction of future Alzheimer’s disease dementia using plasma phospho-tau combined with other accessible measures

(2021) Sebastian Palmqvist et al.   NATURE MEDICINE

Plasma biomarkers of Alzheimer’s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations

(2021) Nicholas C. Cullen et al.   Nature Communications

Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease

(2021) Shorena Janelidze et al.   JAMA Neurology

Characterization of pre‐analytical sample handling effects on a panel of Alzheimer's disease–related blood‐based biomarkers: Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group

(2021) Inge M. W. Verberk et al.   Alzheimers & Dementia

Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study

(2020) Frank de Wolf et al.   BRAIN

Prediction of clinical diagnosis of Alzheimer’s disease, vascular, mixed, and all-cause dementia by a polygenic risk score and APOE status in a community-based cohort prospectively followed over 17 years

(2020) H. Stocker et al.   MOLECULAR PSYCHIATRY

Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer’s disease

(2020) Nicolas R. Barthélemy et al.   JOURNAL OF EXPERIMENTAL MEDICINE

The dynamics of biomarkers across the clinical spectrum of Alzheimer’s disease

(2020) Christoforos Hadjichrysanthou et al.   Alzheimers Research & Therapy

Comparing progression biomarkers in clinical trials of early Alzheimer’s disease

(2020) Nicholas C. Cullen et al.   Annals of Clinical and Translational Neurology

Remote Blood Biomarkers of Longitudinal Cognitive Outcomes in a Population Study

(2020) Kumar B. Rajan et al.   ANNALS OF NEUROLOGY

Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology

(2020) Inge M. W. Verberk et al.   Alzheimers Research & Therapy

Time course of phosphorylated-tau181 in blood across the Alzheimer’s disease spectrum

(2020) Alexis Moscoso et al.   BRAIN

Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline

(2020) Julia Stockmann et al.   Alzheimers Research & Therapy

Plasma phosphorylated tau181 and neurodegeneration in Alzheimer’s disease

(2020) Oskar Hansson et al.   Annals of Clinical and Translational Neurology

TDP‐43 as structure‐based biomarker in amyotrophic lateral sclerosis

(2020) Léon Beyer et al.   Annals of Clinical and Translational Neurology

Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer’s Disease and Correlates with Cognitive Impairment

(2019) Patrick Oeckl et al.   JOURNAL OF ALZHEIMERS DISEASE

Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease

(2019) Oliver Preische et al.   NATURE MEDICINE

Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration

(2019) Nicholas J. Ashton et al.   Acta Neuropathologica Communications

Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer’s disease

(2019) Philip S. J. Weston et al.   Alzheimers Research & Therapy

Incident depression and mortality among people with different types of dementia: results from a longitudinal cohort study

(2019) Laura Perna et al.   SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY

High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis

(2019) Suzanne E. Schindler et al.   NEUROLOGY

Neurofilament light chain — new potential for prediction and prognosis

(2019) Ian Fyfe   Nature Reviews Neurology

Prediction of Alzheimer's disease diagnosis within 14 years through Aβ misfolding in blood plasma compared to APOE4 status, and other risk factors

(2019) Hannah Stocker et al.   Alzheimers & Dementia

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

(2018) Clifford R. Jack et al.   Alzheimers & Dementia

Amyloid blood biomarker detects Alzheimer's disease

(2018) Andreas Nabers et al.   EMBO Molecular Medicine

Amyloid-β-Secondary Structure Distribution in Cerebrospinal Fluid and Blood Measured by an Immuno-Infrared-Sensor: A Biomarker Candidate for Alzheimer’s Disease

(2016) Andreas Nabers et al.   ANALYTICAL CHEMISTRY

Interaction of the Heparin-Binding Consensus Sequence of β-Amyloid Peptides with Heparin and Heparin-Derived Oligosaccharides

(2016) Khanh Nguyen et al.   JOURNAL OF PHYSICAL CHEMISTRY B

Association between Oxidative Stress and Frailty in an Elderly German Population: Results from the ESTHER Cohort Study

(2015) Kai-Uwe Saum et al.   GERONTOLOGY

An infrared sensor analysing label-free the secondary structure of the Abeta peptide in presence of complex fluids

(2015) Andreas Nabers et al.   Journal of Biophotonics

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

(2014) Bruno Dubois et al.   LANCET NEUROLOGY

The Toxicity of Amyloid ß Oligomers

(2012) Li Na Zhao et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Guy M. McKhann et al.   Alzheimers & Dementia